Form 4 for NVCR NovoCure Ltd
Accepted 2025-06-06 00:00:00 ET · period of report 2025-06-04 · accession 0001562180-25-004555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-06 | 2025-06-04 | NVCR | VERNON W ANTHONY | Dir | A - Grant | $0.00 | +11.2K | 179.1K | +7% | $0 |
| D | 2025-06-06 | 2025-06-04 | NVCR | VERNON W ANTHONY | Dir | A - Grant | $0.00 | +16.7K | 16.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-04 | A | A | 11,215 | $0.00 | 179,102 | D | — | — | (F1) Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-06-04 | A | A | 16,697 | $0.00 | 16,697 | D | $16.72 · 2026-06-04 to 2035-06-04 | 16,697 Ordinary Shares | (F2) Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2026 annual general meeting of shareholders. |